https://empesertibinhibitor.co....m/the-gene-based-thr
Persons diagnosed with an ischemic stroke (IS) or a transient ischemic attack (TIA) are susceptible to experiencing a secondary stroke event. Single or dual antiplatelet therapy, for secondary stroke prevention, may be recommended, with the choice determined by the severity and the cause of the stroke. In the United States, this study evaluated outpatient antiplatelet treatment approaches for individuals with SSP, a
Like
Comment
Share
